A jury of experts from science and industry will select the best ideas with the most promising teams from all the project proposals submitted.

A panel of experts with representatives from the international biotechnology scene assesses the project applications for the GO-Bio initial feasibility phase. After a pre-selection, prioritised teams can present their projects to the jury. As a result of this jury meeting, the BMBF receives proposals for funding projects in the GO-Bio initial feasibility phase. The final funding decision is reserved for the BMBF as the funding organisation.

Evaluation criteria for the selection of project ideas

• Necessity and appropriateness of the requested funding
• Innovation level oft the project
• Realisability of the work plan
• Plausibility of the exploitation perspective shown
• Expertise of the team and partners

Members of the expert panel

• Andreas Bergmann - Sphingotec GmbH, Adrenomed AG
• Jessica Bertrand - Experimental Orthopaedics University of Magdeburg
• Inge Bliestle - Bliestle Life Science Consulting
• Michael Burnet - Synovo GmbH
• Uwe Bücheler - Boehringer Ingelheim Pharma GmbH & Co. KG
• Michael Friebe - IDTM GmbH
• Christian Hackenberger - Leibniz Institute for Molecular Pharmacology
• Katja Hanack - University of Potsdam, new/era/mabs GmbH
• Sven Klußmann - Aptarion Biotech AG
• Lena Krzyzak - Neotiv GmbH
• Daniel Mark - Spindiag GmbH
• Peter Pack - Freelance Consultant
• Tanja Rosenmund - SPARK BIH, Charité BIH Innovation
• Ulrich Rothbauer - Pharmaceutical Biotechnology, NMI Reutlingen
• Dirk Scholl - Founder of Dynamic Biosensors GmbH
• Barbara Seliger - Institute for Medical Immunology, University Hospital Halle/Saale
• Marion Subklewe - Munich University Hospital
• Jörg Traub - MedTech Pharma e.V., Bayern Innovativ GmbH
• Andrea Tüttenberg - ActiTrexx GmbH
• Ralf Wagner - Institute for Medical Microbiology and Hygiene, University of Regensburg
• Heike A. Wieland - Sanofi-Aventis Deutschland GmbH